BioLineRx ADS Representing 15
Stock
Stock
ISIN: US09071M2052
Ticker: BLRX
US09071M2052
BLRX
Price
Price
Frequently asked questions
What is BioLineRx ADS Representing 15's market capitalization?
The market capitalization of BioLineRx ADS Representing 15 is $34.65M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for BioLineRx ADS Representing 15?
BioLineRx ADS Representing 15's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0508. EPS indicates the company's profitability on a per-share basis.
What is BioLineRx ADS Representing 15's revenue over the trailing twelve months?
Over the trailing twelve months, BioLineRx ADS Representing 15 reported a revenue of $11.65M.
What is the EBITDA for BioLineRx ADS Representing 15?
BioLineRx ADS Representing 15's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$36.93M. EBITDA measures the company's overall financial performance.
What is the free cash flow of BioLineRx ADS Representing 15?
BioLineRx ADS Representing 15 has a free cash flow of -$28.89M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of BioLineRx ADS Representing 15's stock?
The 5-year beta for BioLineRx ADS Representing 15 is 1.26. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does BioLineRx ADS Representing 15 have, and what sector and industry does it belong to?
BioLineRx ADS Representing 15 employs approximately 79 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.
What is the free float of BioLineRx ADS Representing 15's shares?
The free float of BioLineRx ADS Representing 15 is 1.20B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$34.65M5Y beta
1.26EPS (TTM)
-$0.0508Free Float
1.20BRevenue (TTM)
$11.65MEBITDA (TTM)
-$36.93MFree Cashflow (TTM)
-$28.89MPricing
1D span
$0.267$0.359
52W span
$0.261$1.89
Information
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
79
Biotechnology & Drugs
Health Care
Identifier
ISIN
US09071M2052
Primary Ticker
BLRX